Boehringer Ingelheim has published results from the 52-week DYNAGITO study in The Lancet Respiratory Medicine showing that the Stiolto Respimat tiotropium bromide/olodaterol soft mist inhaler produced a 7% greater reduction in moderate-to-severe COPD exacerbations than the Spiriva Respimat tiotropium bromide SMI. According to BI, that reduction was "not reaching the … [Read more...] about Boehringer Ingelheim publishes results of study comparing Stiolto Respimat and Spiriva Respimat for COPD
News
Arch Biopartners gets US patent for its AB569 antibacterial inhalation solution
According to Arch Biopartners, the US Patent and Trademark Office has issued US Patent 9,925,206, “Compositions and Methods for Treating Bacterial Infection,” which covers the composition of AB569 sodium nitrite/ethylenediaminetetraacetic acid (EDTA), to the University of Cincinnati. Arch acquired an exclusive license for AB569 from the university in March 2016 … [Read more...] about Arch Biopartners gets US patent for its AB569 antibacterial inhalation solution
Convexity Scientific launches Flyp handheld ultrasonic nebulizer
US-based Convexity Scientific has announced the availability of its Flyp handheld ultrasonic nebulizer, which the company says received FDA clearance in May 2017. The Flyp nebulizer is lighter weight than a smartphone, the company said, with a rechargeable lithium-ion battery, and delivers most medications in about 7 minutes. Convexity is selling the Flyp nebulizer … [Read more...] about Convexity Scientific launches Flyp handheld ultrasonic nebulizer
Verona reports positive Phase 2b results for RPL554
Verona Pharma has announced that a Phase 2b study of its RPL554 inhaled PDE3/PDE4 inhibitor met its primary endpoint, demonstrating significant improvement in FEV1 compared to placebo at 4 weeks in patients with moderate-to-severe COPD for all 4 doses tested. The study also met secondary endpoints, with significant improvements in 12-hour average FEV1, respiratory … [Read more...] about Verona reports positive Phase 2b results for RPL554
Adherium’s Smartinhaler SmartTouch for Symbicort sensor gets 510(k) OTC clearance
According to Adherium, the FDA has okayed over-the-counter (OTC) sales of the company's Smartinhaler sensor for AstraZeneca’s Symbicort MDI. The 510(k) OTC clearance will allow patients to purchase the sensor without a prescription at local pharmacies or online. In 2015, Adherium announced that it had partnered with AstraZeneca to provide sensors for use in the … [Read more...] about Adherium’s Smartinhaler SmartTouch for Symbicort sensor gets 510(k) OTC clearance
Evoke announces modification of agreement with Mallinckrodt on Gimoti development
Evoke Pharma announced that an amendment of its agreement with Mallinckrodt allows for deferral of milestone payments due on acceptance of review of the company's NDA for Gimoti intranasal metoclopramide for the treatment of gastroparesis in women and on final approval. The agreement now allows for a single milestone payment that will be due a year after FDA approval … [Read more...] about Evoke announces modification of agreement with Mallinckrodt on Gimoti development
Acorda files MAA for Inbrija inhaled levodopa
Acorda Therapeutics has submitted a marketing authorization application to the EMA for its Inbrija levodopa DPI for the treatment of OFF periods in Parkinson's disease patients, the company said. The application is supported by data from the Phase 3 SPAN-PD trial, which demonstrated improved motor function in Parksinson's patients experiencing OFF periods, and … [Read more...] about Acorda files MAA for Inbrija inhaled levodopa
Hovione provides update on expansion of manufacturing sites
Hovione has provided an update on its ongoing expansion of manufacturing sites in Portugal, Ireland and the US, saying that it has already added significant capacity to the Portuguese and US facilities and has plans to add more in Portugal and Ireland over the next 5 years. According to the company, the expansion in facilities has also led to a 39% increase in … [Read more...] about Hovione provides update on expansion of manufacturing sites
Orion gets positive opinion for salmeterol/fluticasone Easyhaler in EU under the decentralized procedure
Orion Corporation has announced that its salmeterol/fluticasone Easyhaler combination DPI has received a positive opinion under the EU's decentralized procedure, with Sweden as the reference member state. Orion had announced in December 2016 that it planned to submit an MAA in early 2017 based on positive results from a PK study. According to Orion, it will now … [Read more...] about Orion gets positive opinion for salmeterol/fluticasone Easyhaler in EU under the decentralized procedure
Intranasal ketamine trial halted due to side effects
According to an article published March 15, 2018 in the Journal of Psychopharmacology, a pilot trial of intranasal ketamine for the treatment of severe depression conducted by researchers from the University of New South Wales (UNSW) and the Black Dog Institute was suspended due to poor tolerability. The trial was halted after the first 5 patients dosed … [Read more...] about Intranasal ketamine trial halted due to side effects